Cargando…
Amsler Grid Versus 10-2 Test in Primary Open Angle Glaucoma
BACKGROUND: Glaucoma is the leading cause of global irreversible blindness. The goal of management in glaucoma lies in its early detection and treatment to prevent further optic neuropathy. Available equipment for early glaucoma detection is not cost-effective or readily available in resource-scarce...
Autores principales: | Gbadegesin, Temitope Mariam, Olawoye, Olusola, Sarimiye, Tarela Frederick, Idowu, Oluwatobi Olalekan, Ajayi, Benedictus G.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204916/ https://www.ncbi.nlm.nih.gov/pubmed/37228887 http://dx.doi.org/10.4103/jwas.jwas_275_22 |
Ejemplares similares
-
Comparison of Ocular Biomery in Primary Open Angle Glaucoma and Non-glaucoma in South West Nigeria
por: Oluwaniyi, Ajibola Toyin, et al.
Publicado: (2023) -
Amsler grid test for detection of advanced glaucoma in Ethiopia
por: Gessesse, Girum W., et al.
Publicado: (2020) -
Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
por: Olawoye, Olusola, et al.
Publicado: (2018) -
Exfoliation syndrome in Northern Nigeria
por: Idakwo, Ugbede, et al.
Publicado: (2018) -
MacuFix® versus Amsler grid for metamorphopsia categorization for macular diseases
por: Claessens, Daniela, et al.
Publicado: (2021)